These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4119343)

  • 1. [Lipid metabolism in women ingesting gestagens as contraceptives].
    Pisarek-Miedzińska D; Roszkowski I; Firek A
    Ginekol Pol; 1972; 43(12):1407-19. PubMed ID: 4119343
    [No Abstract]   [Full Text] [Related]  

  • 2. Fertility control with 15-8-5.
    Andelman MB
    Fertil Steril; 1970 Apr; 21(4):314-21. PubMed ID: 4101384
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of chlormadinone acetate and mestranol on blood glucose and plasma insulin. II. Twelfth month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Fertil Steril; 1971 Apr; 22(4):224-8. PubMed ID: 4101970
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protein metabolism in women using Femigen Polfa as peroral contraceptives].
    Firek A; Pisarek-Miedzińska D; Wójcicka J; Korc R
    Ginekol Pol; 1973 Nov; 44(11):1303-8. PubMed ID: 4129073
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of chlormadinone acetate and mestranol on blood glucose and plasma insulin. I. Six-month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Fertil Steril; 1971 Apr; 22(4):217-23. PubMed ID: 4101969
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives.
    Zorrilla E; Hulse M; Hernandez A; Gershberg H
    J Clin Endocrinol Metab; 1968 Dec; 28(12):1793-6. PubMed ID: 4177383
    [No Abstract]   [Full Text] [Related]  

  • 7. Endometrial morphology after sequential medication with mestranol and chlormadinone.
    Ober WB; Decker A; Clyman MJ; Roland M
    Obstet Gynecol; 1966 Aug; 28(2):247-53. PubMed ID: 4161461
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of combined and low-dose gestagen oral contraceptives on plasma lipids; including individual phospholipids.
    Larsson-Cohn U; Berlin R; Vikrot O
    Acta Endocrinol (Copenh); 1970 Apr; 63(4):717-35. PubMed ID: 4194179
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of oral contraceptives on glycerides and sterol esters of human cervical mucus.
    Singh EJ; Swartwout JR
    Am J Obstet Gynecol; 1972 Oct; 114(4):484-91. PubMed ID: 4120115
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytohormonal findings in patients using various forms of contraception.
    Reyniak JV; Sedlis A; Stone D; Connell E
    Acta Cytol; 1969 Jun; 13(6):315-22. PubMed ID: 4184413
    [No Abstract]   [Full Text] [Related]  

  • 11. [Towards a more physiological hormonal contraception].
    Stĕrba R
    Zentralbl Gynakol; 1970 Mar; 92(10):303-12. PubMed ID: 4096927
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of chloramdinone and chlormadinone with mestranol preparations on the blood clotting system].
    Marcinkowski Z
    Ginekol Pol; 1978 Mar; 49(3):211-7. PubMed ID: 77805
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of the oral contraceptive Ovosiston on the composition of human milk.
    Ramadan MA; Salah MM; Eid SZ; Sammour MB
    J Reprod Med; 1972 Aug; 9(2):81-3. PubMed ID: 4115112
    [No Abstract]   [Full Text] [Related]  

  • 14. [1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics].
    Gödel E; Gödel B
    Dtsch Gesundheitsw; 1970 Apr; 25(14):627-31. PubMed ID: 4098543
    [No Abstract]   [Full Text] [Related]  

  • 15. Cooperative studies of sequens, a sequential oral contraceptive agent, in Japan.
    Sawasaki C; Ashitaka Y
    J Jpn Obstet Gynecol Soc; 1968 Apr; 15(2):96-107. PubMed ID: 4175084
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of Gestranol used as a contraceptive on the level of some aminotransferases].
    Giermańska T; Jabloński K; Filc-Bauer A
    Pol Tyg Lek; 1972 Nov; 27(47):1839-40. PubMed ID: 4118898
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum protein -(Xh)-changes in pregnancy and use of ovulation inhibitons in women and men].
    Geserick G; Müller G
    Zentralbl Gynakol; 1970 Sep; 92(37):1195-200. PubMed ID: 4098488
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential estrogen and progestogen therapy. A clinical evaluation.
    Abrams AA
    Am J Obstet Gynecol; 1966 Dec; 96(7):1005-10. PubMed ID: 4162848
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone alterations by a sequential-type oral contraceptive.
    Spellacy WN; Buhi WC; Bendel RP
    Obstet Gynecol; 1969 Apr; 33(4):506-10. PubMed ID: 4180423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.